← Back to patent-cliff list
CAS 17106-13-7
2,4-dimethyl-1H-pyrrole-3-carboxylic acid
Codes：SUNT-017
Application context (from source-drug indications)
胰腺神经内分泌肿瘤苹果酸舒尼替尼肾细胞癌苹果酸舒尼替尼胃肠道间质瘤苹果酸舒尼替尼骨肉瘤苹果酸舒尼替尼肉瘤苹果酸舒尼替尼淋巴瘤苹果酸舒尼替尼
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| 苹果酸舒尼替尼Sunitinib Malate | Tier B — Position early | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
N1,N1-diethylethane-1,2-diamine→N-(2-(diethylamino)ethyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide→ethyl 2,4-dimethyl-1H-pyrrole-3-carboxylate→2,4-dimethyl-1H-pyrrole-3-carboxylic acid→5-fluoro-2-oxoindoline-3-carbaldehyde
Intermediates available on this site
Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.
| Supplier | Product | Price band | MOQ | Lead time | Qualifications |
|---|---|---|---|---|---|
| Qualified Partner — East China API Works | 5-Fluoro-2-oxindole Pharmaceutical Intermediates | 询价 | 询价 | 询价 | — |
| Unibest Nantong cGMP Site | 5-Formyl-2,4-dimethyl-1H-pyrrole-3-carboxylic acid Pharmaceutical Intermediates | 询价 | 询价 | 询价 | — |
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.